# Ergometrine

## Ergometrine 0.2mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                             |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OERGO                                                                                                                                                                                                                                                                                                            |
| 適應症     | Postpartum haemorrhage caused by uterine atony.                                                                                                                                                                                                                                                                  |
| 用法用量   | Adult 1 tablet TID. the maximum dose: 2 mg/day. [Micromedex 2021/08/04] Postpartum hemorrhage; Treatment and Prophylaxis: Minimization of late postpartum hemorrhage, 0.2 to 0.4 mg (1 or 2 tablets ) orally or sublingually every 6 to 12 hours until the danger of uterine atony has passed, usually 48 hours. |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                     |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                     |
| 禁忌       | Threatened spontaneous abortion, vascular diseases, impaired renal or hepatic function, pregnancy, induction of labor.                                                                                                                                                                                           |
| 副作用     | Nausea, vomiting, headache, dizziness, abdominal pain, hypertension, bradycardia, dyspnea, ergotism.                                                                                                                                                                                                             |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                  |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                 |

